Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Smoking Cessation × DMAC2L protein, human × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Recurrence 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Leiomyoma 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Tobacco Use Cessation Devices 11 Varenicline 9 Surveys and Questionnaires 8 Nicotine Replacement Therapy 7 Standard of Care 4 Motivational Interviewing 4 Preoperative Exercise 3 Methods 3 Ethanol 3 Videotape Recording 2 Tomography, X-Ray Computed 2 Tobacco Products 2 Smoking Devices 2 Secondary Prevention 2 Nicotine Chewing Gum 2 Mindfulness 2 Interviews as Topic 2 Hematologic Tests 2 Focus Groups 2 Cognitive Behavioral Therapy 2 Carbon Monoxide 2 Bupropion 2 Aspirin 2 thiamine triphosphorate 1 sulforaphane 1 polyphenon E 1 cytisine 1 Yoga 1 Urinalysis 1 Transdermal Patch 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00827866 2014-11-25

Efficacy of Tobacco Quitline for Cancer Survivors

St. Jude Children's Research Hospital

Phase NA Completed

Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡